Related Experiment Video
Updated: Jun 30, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Diastolic dysfunction: a link between hypertension and heart failure
Sophie Lalande1, Bruce D Johnson
1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Insights
Diastolic heart failure, marked by preserved ejection fraction, stems from impaired left ventricular (LV) relaxation and compliance, often linked to hypertension. Early blood pressure control is key to prevention.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Diastolic heart failure presents with heart failure symptoms and preserved ejection fraction.
- Diagnosis is often by exclusion due to indistinguishable symptoms from systolic dysfunction.
- Hypertension is a common precursor, leading to left ventricular (LV) concentric hypertrophy.
Purpose of the Study:
- To elucidate the pathophysiology of diastolic heart failure.
- To highlight the role of hypertension in its development.
- To outline current treatment and prevention strategies.
Main Methods:
- Review of existing literature on diastolic heart failure and hypertension.
- Analysis of the mechanisms linking hypertension to LV diastolic dysfunction.
- Synthesis of treatment and prevention guidelines.
Main Results:
- Diastolic dysfunction arises from decreased LV compliance and relaxation, exacerbated by hypertension-induced LV hypertrophy and collagen accumulation.
- Hypertension leads to LV concentric hypertrophy, reducing compliance and diastolic filling.
- Fibrillar collagen accumulation contributes to decreased compliance and diastolic dysfunction.
Conclusions:
- Pharmacological treatment should target blood pressure normalization, LV hypertrophy regression, heart rate control, and symptom management.
- Preventive strategies focusing on early and aggressive blood pressure control are crucial.
- Effective management of hypertension is paramount in reducing diastolic heart failure incidence.
Abstract:
Diastolic heart failure is characterized by the symptoms and signs of heart failure, a preserved ejection fraction and abnormal left ventricular (LV) diastolic function caused by a decreased LV compliance and relaxation. The signs and symptoms of diastolic heart failure are indistinguishable from those of heart failure related to systolic dysfunction; therefore, the diagnosis of diastolic heart failure is often one of exclusion. The majority of patients with heart failure and preserved ejection fraction have a history of hypertension. Hypertension induces a compensatory thickening of the ventricular wall in an attempt to normalize wall stress, which results in LV concentric hypertrophy, which in turn decreases LV compliance and LV diastolic filling. There is an abnormal accumulation of fibrillar collagen accompanying the hypertension-induced LV hypertrophy, which is also associated with decreased compliance and LV diastolic dysfunction. There are no specific guidelines for treating diastolic heart failure, but pharmacological treatment should be directed at normalizing blood pressure, promoting regression of LV hypertrophy, preventing tachycardia and treating symptoms of congestion. Preventive strategies directed toward an early and aggressive blood pressure control are likely to offer the greatest promise for reducing the incidence of diastolic heart failure.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Mitral Regurgitation I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure Drugs: Diuretics
